AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

First Global Phase 3 Study in Patients with Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer Results Featured in a Presidential Symposium at ESMO and Simultaneously Published in the New England Journal of Medicine (NEJM) THOUSAND OAKS, Calif., Oct. 22, 2023 /PRNewswire/ –…

Click here to view original post